发明公开
- 专利标题： HETEROCYCLIC COMPOUND
- 专利标题（中）： 杂种优良品种VERBINDUNG
-
申请号： EP14856224申请日： 2014-10-22
-
公开(公告)号： EP3061754A4公开(公告)日： 2017-03-22
- 发明人: SETO MASAKI , BANNO YOSHIHIRO , IMAEDA TOSHIHIRO , KAJITA YUICHI , ASHIZAWA TOMOKO , KAWASAKI MASANORI , NAKAMURA SHINJI , MIKAMI SATOSHI , NOMURA IZUMI , TANIGUCHI TAKAHIKO , MARUI SHOGO
- 申请人： TAKEDA PHARMACEUTICALS CO
- 专利权人： TAKEDA PHARMACEUTICALS CO
- 当前专利权人： TAKEDA PHARMACEUTICALS CO
- 优先权： JP2013220194 2013-10-23
- 主分类号： C07D239/28
- IPC分类号： C07D239/28 ; A61K31/426 ; A61K31/4965 ; A61K31/497 ; A61K31/505 ; A61K31/506 ; A61K31/5377 ; A61K31/5386 ; A61K31/55 ; A61P25/18 ; A61P25/28 ; A61P43/00 ; C07D239/36 ; C07D239/42 ; C07D239/47 ; C07D239/48 ; C07D239/54 ; C07D239/56 ; C07D241/24 ; C07D241/26 ; C07D277/20
摘要：
The problem of the present invention is to provide a compound having a PDE2A inhibitory action, and useful as a prophylactic or therapeutic drug for schizophrenia, Alzheimer's disease and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof.
信息查询
